Media Zoom
SK Bioscience developing combo flu and COVID-19 vaccine, a first of its kind in South Korea
2022.02.25
SK Bioscience Ltd. is developing a vaccine intended to simultaneously immunize people against the flu and COVID-19. It is the first vaccine of its type to be developed in South Korea and will use the technology from Skycellflu, a cell-cultivated influenza vaccine developed by the Seongnam-si, South Korea-based company.